PHILADELPHIA – The American Society for Clinical Pathology (ASCP) has named two faculty members in the Perelman School of Medicine at the University of Pennsylvania, Kevin Alby, PhD and Roseann Wu, MD, to the society’s 2016 “40 under Forty” list. Both are assistant professors of Pathology and Laboratory Medicine. The award, now in its third year, honors the top 40 pathologists, residents, and laboratory professionals under the age of 40 who are making significant contributions to the profession. Nominees represent the achievements and qualities important to the pathology and laboratory sciences fields and stand out as the future of laboratory leadership.
Alby received his doctorate in Pathobiology from Brown University and completed a fellowship in Clinical Microbiology at the University of North Carolina Hospitals. He is an assistant director of the Clinical Microbiology Laboratory at the Hospital of the University of Pennsylvania (HUP), where he focuses on the implementation of new technology such as multiplex PCR assays and MALDI-TOF mass spectrometry. The ASCP cited Alby for his active role in professional organizations, selecting roles that allow him to serve as a mentor to others in his field.
Wu received her medical and masters in public health degrees from the Icahn School of Medicine at Mount Sinai. She received her AP/CP residency from Massachusetts General Hospital, where she was chief resident and a Priscilla D. Taft Fellow in Cytopathology. Also specializing in cytopathology at HUP, she is a member of the Anatomic Pathology Division. The ASCP cited Wu for her use of innovative methods for delivering education and involvement in adaptive e-learning initiatives.
In 2014, Anna Moran, an assistant professor of Pathology and Laboratory Medicine at Penn Presbyterian Medical Center, was one of the inaugural 40 under 40 ASCP program members.
The link to ASCP announcement contains profiles of Alby and Wu.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.